Search results for: “MustGrow”

Summary: MustGrow Biologics Corp. has announced successful results from its two-year field trial program in the Canadian Prairies. The trials demonstrate that TerraMG™, a mustard-derived organic biocontrol, effectively suppresses Clubroot disease in canola. Results showed up to a 95% reduction in resting spores and a yield increase of up to 7 bushels per acre, providing…

Summary: MustGrow Biologics Corp. has successfully completed a two-year field trial program demonstrating that its mustard-derived technology, TerraMG™, effectively suppresses Clubroot—a devastating soil-borne disease in canola. Trial results showed up to a 95% reduction in Clubroot spores and yield increases of up to 7 bushels per acre, providing a potential breakthrough for Canadian farmers who…

MustGrow Biologics Corp. has reported outstanding performance metrics for its organic biofertility product, TerraSante™. In large-scale U.S. field trials, the mustard-derived solution delivered a 2-ton per acre yield increase for potato growers, translating to approximately US$5,000 in added value per acre, confirming its potential to revolutionize regenerative agriculture practices. MustGrow Reports Significant U.S. Potato Yield…

MustGrow and Phospholutions Partner to Launch RhizoSorb® Phosphorus Efficiency Technology in Canada SASKATOON, Saskatchewan | June 10, 2025 – In a strategic move to promote sustainable agriculture and nutrient efficiency, MustGrow Biologics Corp. (TSXV:MGRO) (OTC:MGROF) (FRA:0C0) has announced a new distribution agreement with Phospholutions Inc. for the phosphorus efficiency technology RhizoSorb®. Under this agreement, MustGrow…

MustGrow Reports First Quarter 2025 Results, Achieving $3.8 Million in Sales Revenue SASKATOON, Saskatchewan, Canada – May 27, 2025 – MustGrow Biologics Corp. (TSXV:MGRO) (OTC:MGROF) (FRA:0C0) (the “Company” or “MustGrow”), a leading provider of biological and regenerative agriculture solutions, has announced its operating and financial results for the three months ended March 31, 2025. For…

MustGrow Biologics Corp. is pleased to announce the execution and closing of an Asset Purchase Agreement (APA) with Univar Solutions Canada Ltd. for the acquisition of certain assets that represent NexusBioAg. The agreement, dated December 31, 2024, marks a strategic move to strengthen MustGrow’s position as a leading provider of biological and regenerative agriculture solutions.…

MustGrow Biologics Corp., a frontrunner in the biological and regenerative agriculture space, has announced the signing of a non-binding term sheet for the proposed acquisition of NexusBioAg, a division of Univar Solutions Canada Ltd. This monumental step is set to transform MustGrow into a fully integrated provider of biological solutions, further solidifying its position as…

In an era where sustainable agricultural practices are more crucial than ever, MustGrow Biologics Corp. is positioning itself at the forefront of innovation in biofertility and biocontrol solutions. The company’s commitment to harnessing the natural defenses of the mustard plant is not just a scientific endeavor; it represents a paradigm shift towards more environmentally friendly…